Top Tweets for #ApTOLL
ఏపీ వాహనదారులకు గుడ్ న్యూస్, ఇక టోల్ ప్లాజాల వద్ద ఆగక్కర్లేదు!
#APToll #BarrierFreeToll #FASTag #AndhraPradesh #NH44 #Chandrababu #APHighways #SmartTolling #DigitalIndia #GPSBasedTolling #HyderabadBangaloreHighway #TollPlaza #HighwayTravel #TrafficFree #FuelSaving #FutureTech
#ApTOLL’s secondary analysis data of APRIL 1b/2a trial published in scientific journal “Stroke” from @American_Heart:
https://t.co/NCtGF3BKtZ
#stroke #AcuteIschemicStroke #cerebroprotection
Alegría de que una intervención terapéutica para #ictus desarrollada por un grupo de #RICORSICTUS dé un importante paso hacia su aplicación clínica 👏😃
#ApToll
@SaludISCIII @sanidadgob @CienciaGob @AptaTargets
@MerckHealthcare
👇
We are excited to announce an agreement with @MerckHealthcare for the clinical development and commercialization of #ApTOLL, a Toll-like receptor 4 (TLR4) antagonist being developed for acute ischemic stroke.
Learn more: https://t.co/MXscgFtEyv
#healthcare #innovation
We are excited to announce an agreement with @MerckHealthcare for the clinical development and commercialization of #ApTOLL, a Toll-like receptor 4 (TLR4) antagonist being developed for acute ischemic stroke.
Learn more: https://t.co/MXscgFtEyv
#healthcare #innovation
Hot!: our perspective on the great future for #aptamers on #Neurology:
@makimhj & @FdeCastroS (2025) @NRRNeural
Comparing aptamers vs #small_molecules vs #antibodies.
Our dream?: #ApToll as #remyelinating for #MS etc.
https://t.co/W2nRTSgItb
@InstitutoCajal @AptaTargets @SENC_
A new study shows the cerebroprotective effects of #ApTOLL on mice with #AcuteIschemicStroke: https://t.co/2grZgxOa6E
The study, published in "Pharmaceutics" (@MDPIpharma), was conducted by researchers at aptaTargets (Dr. Macarena Hernández) and @IISLaFe (Dr. Juan Salom).
2/2 #ApTOLL diminishes damage in EAE in vivo,promotes OPCs differentiation+#myelin formation in vivo+in vitro in murine & #human OPCs! A collaborative research between @AptaTargets & @InstitutoCajal with a #DoctoradoIndustrial/@ComunidadMadrid Full open-access thanks to @CSIC
Very happy!: #ApTOLL as #neuroprotector+#remyelinating agent in in vivo+in vitro models of #MultipleSclerosis now published in @BrJPharmacol.
Superb preclinical studies,this #aptamer is a hope for #MS patients waiting for #clinicaltrials. @AptaTargets 🧵👇🏼
https://t.co/CItka7gmuE
We are thrilled to announce that over 1,000 companies in Europe, aptaTargets was selected for the #EICAccelerator by @EUeic.
It secures €2.5M grant to start the Phase 2b clinical trial with #ApTOLL in patients with #AcuteIschemicStroke:
https://t.co/kPy7tuFviG
aptaTargets, that has obtained the Seal of Excellence 🏅 from the #EICAccelerator, has been selected by the @ComunidadMadrid to receive a direct grant of €1.940M: https://t.co/ZAfDi4QTsF
#ApTOLL #neuroprotection #AcuteIschemicStroke #EUeic #HorizonEurope #NextGenerationEU
In San Francisco for the @jpmorgan Healthcare Conference week!
#JPM24 #ApTOLL #DrugDevelopment #neuroprotection #AcuteIschemicStroke #AcuteMyocardialInfarction
Our CEO David Segarra and our BD Director David Saxner will attend #JPM24 in San Francisco.
If you are interested to explore partnerships with our #ApTOLL program, please send us a meeting request: [email protected]
https://t.co/zEIejNERWy
#neurovascular #neurology
Two papers recently accepted on #remyelinating (+#neuroprotecting) compounds for #MS/#MultipleSclerosis: on @WileyNeuro by blocking #LRKK2, and on @BrJPharmacol with #ApTOLL (@AptaTargets). #Hot #major #challenge for #Neurology: detailed preclinical for strong #clinical_trial.
Tomorrow I’ll be participating in th SLICE Worldwide meeting. Looking forward to sharing our experience in the APRIL trial! #stroke #ApTOLL #cytoprotection https://t.co/oetnqx7Pnu
This week, the biotech sector is in #BioSpain2023! Our CEO David Segarra and our CFO Maria Eugenia Zarabozo just arrived in Barcelona 👏🏼
+2,000 attendees, 800 companies and 4,000 partnering meetings
#ApTOLL #AcuteIschemicStroke #AcuteMyocardialInfarction #aptamers
Un tratamiento del 12 de Octubre y la UCM reduce la mortalidad en ictus del 18 al 5%
#12deOctubre #ApTOLL #fármaco #Ictus #InstitutodeSaludCarlosIII #Madrid #Madrid24h #Medicina #pacientes #Portada #RamónyCajal #salud #seguridad #UCM #Universidad
https://t.co/emlu6zCOQP
Neuroprotector #ApTOLL Hopeful in #Stroke; Late-Pandemic STEMIs; Exercise vs Risky Carotids? Recent developments of interest in cardiovascular medicine by @nicolejlou, medical reporter at @medpagetoday:
https://t.co/c5WiAVof8f
#aptamers #innovation #neurology
The prestigious scientific journal @JAMANeuro has published today the results from Phase 1b/2a clinical trial of the neuroprotective drug #ApTOLL for #AcuteIschemicStroke 🧠: https://t.co/WGO3EFnKjX
#aptamers #neurology #CNS
Last Seen Hashtags on Sotwe
gay roblox
Seen from Sweden
thedivisonresurgence
Seen from Venezuela
SonAmy
Seen from Poland
nolimit(*****)******+filter:native_video
Seen from Brazil
bodyswap
Seen from Brazil
NOlimit filter:videos
Seen from United States
睾丸を蹴る
Seen from Germany
Wien18plus
Seen from Thailand
CD
Seen from Korea
colmek
Seen from Netherlands
Trends for you
Most Popular Users
Elon Musk 
@elonmusk
240.2M followers
Barack Obama
@barackobama
119.3M followers
Donald J. Trump
@realdonaldtrump
111.6M followers
Cristiano Ronaldo
@cristiano
109M followers
Narendra Modi
@narendramodi
107M followers
Rihanna
@rihanna
97.3M followers
NASA
@nasa
92.1M followers
Justin Bieber
@justinbieber
90.6M followers
KATY PERRY
@katyperry
86.9M followers
Taylor Swift
@taylorswift13
80.7M followers
Lady Gaga
@ladygaga
72.2M followers
Kim Kardashian
@kimkardashian
69.4M followers
YouTube
@youtube
68.6M followers
Virat Kohli
@imvkohli
68.6M followers
Bill Gates
@billgates
63.4M followers
The Ellen Show
@theellenshow
62.5M followers
CNN
@cnn
61.9M followers
Neymar Jr
@neymarjr
61.2M followers
X
@x
60.9M followers
Selena Gomez
@selenagomez
59.9M followers